News | July 06, 2022
CEPI and Codiak BioSciences partner to develop protective Betacoronavirus vaccine
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
The company has posted net profit of Rs.39.71 crores for the Financial Year ended March 31, 2022.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
The drug will be manufactured at the group’s topical facility at Ahmedabad
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
Subscribe To Our Newsletter & Stay Updated
